Journals in Life sciences

Asian Journal of Psychiatry

ISSN: 1876-2018
5 Year impact factor: 4.8
Impact factor: 3.8

The Asian Journal of Psychiatry is a general and comprehensive journal of psychiatry for psychiatrists, mental health clinicians, neurologists, physicians, students of mental health and those involved in mental health policy development.The journal aims to bridge a knowledge gap of the application and transfer of research findings and clinical practice through Asia to and from the rest of the world. It aims to focus on psychiatric research pertinent to Asia produced either within or from outside the continent. This may include preclinical, clinical, service system and policy development research relevant to psychiatry and will highlight the socio-cultural diversity of the region as it pertains to mental health.The Asian Journal of Psychiatry publishes peer reviewed original research articles; review articles; commentaries on significant articles; synopses of current research highlights from Asia; and letters to the editor.Submit your vital research today!Twitter: @PsychiatryAsian

Atherosclerosis

ISSN: 0021-9150
5 Year impact factor: 5.3
Impact factor: 4.9

Atherosclerosis brings together, from all sources, papers concerned with investigation on atherosclerosis, its risk factors, and clinical manifestations. Atherosclerosis covers basic and translational clinical and population research approaches to arterial and vascular biology and disease, as well as their risk factors which include: disturbances of lipid and lipoprotein metabolism, diabetesand hypertension, thrombosis, and inflammation. Atherosclerosis particularly welcomes original or review papers regarding the pathogenesis, the environmental, genetic, and epigenetic basis, and the diagnosis, treatment, and risk factors of atherosclerosis and related diseases.Complimentary online access is available to all members of the European Atherosclerosis Society. A reduced personal subscription rate is available to all members of the International Atherosclerosis Society.

Autoimmunity Reviews

ISSN: 1568-9972
5 Year impact factor: 9.3
Impact factor: 9.2

Autoimmunity Reviews will publish up-to-date, structured reviews on diverse topics in autoimmunity, written by first-class experts in the field. The articles will include demonstrative illustrations and tables and will all have a "take-home" message.Articles will principally be invited by the Editors-in-Chief upon the recommendations of the international Editorial Board, and will cover all fields of autoimmunology, bridging the gap between basic and clinical sciences. Contributions in basic sciences will include those on the pathophysiology and mechanisms of disorders as well as genomics and proteomics; clinical contributions will focus upon the diseases, novel therapies and clinical associations.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Behavioural Brain Research

ISSN: 0166-4328
5 Year impact factor: 2.8
Impact factor: 2.6

Behavioural Brain Research is an international, interdisciplinary journal dedicated to the publication of articles in the field of behavioural neuroscience, broadly defined. Contributions from the entire range of disciplines that comprise the neurosciences, behavioural sciences or cognitive sciences are appropriate, as long as the goal is to delineate the neural mechanisms underlying behaviour. Thus, studies may range from neurophysiological, neuroanatomical, neurochemical or neuropharmacological analysis of brain-behaviour relations, including the use of molecular genetic or behavioural genetic approaches, to studies that involve the use of brain imaging techniques, to neuroethological studies. The journal considers research in a wide variety of species including invertebrates, vertebrates, and humans. Reports of original research, of major methodological advances, or of novel conceptual approaches are all encouraged. Behavioural Brain Research also considers critical reviews and meta-analyses.Benefits to authors We provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center.

Best Practice & Research Clinical Endocrinology & Metabolism

ISSN: 1521-690X
5 Year impact factor: 6.3
Impact factor: 6.1

Best Practice & Research Clinical Endocrinology & Metabolism is a topical serial publication integrating the results from the latest original research into practical, evidence-based review articles that seek to address the key clinical issues of diagnosis, treatment and patient management.Each issue follows a problem-orientated approach which focuses on the key questions to be addressed, clearly defining what is known and highlighting topics for future research. Management is described in practical terms so that it can be applied to the individual patient. The series is aimed at the physician either in practice or in training.In practical paperback format, each 200 page issue of Best Practice & Research Clinical Endocrinology & Metabolism provides a comprehensive review of clinical practice and thinking within one specific area of endocrinology and metabolism.Each issue, written by an international team of contributors and guest edited by a renowned expert, form part of a continuous update of current clinical practice.• Attractive format and two-colour text layout • Six issues published annually • Highlighting the latest 'best practice' and 'clinical evidence' • Topic-based, problem-orientated approach • Recommendations on diagnosis, treatment and patient managementThe objective of the series is to provide the physician with the most up-to-date source of information in the field.

BioSystems

ISSN: 0303-2647
5 Year impact factor: 1.8
Impact factor: 2

BioSystems encourages theoretical, computational, and experimental articles that link biology, evolutionary concepts, and the information sciences. The journal is dedicated to publishing research on self-organizing information systems—with the goal of obtaining a better understanding of the origins of biochemical, genetic, epigenetic, physiological, cognitive, linguistic, sociocultural, and biological organization and evolution.The scope of the journal encompasses the fundamental nature of biological information and (self)-organization. This includes quantum phenomena in information transfer, natural computing, biological coding systems, biological complexity, theoretical biology, artificial life, computational modeling of complex biological systems, evolutionary models of computation, application of biological principles to the design of novel computing systems, and the use of biomolecular materials to synthesize artificial systems that capture essential principles of natural biological information processing.The journal does not publish purely medical, computational, or ecological research, unless it is clearly linked to the basic and conceptual aspects of biological organization.The editors encourage articles that deal, in particular, with the following topics:Biological computationMolecular recognitionPhysical foundations of biologyQuantum phenomena in biological systemsCellular controlNeuromolecular computingBiological coding systemsMolecular computing processesSelf-organizing and self-replicating systemsOrigin of the genetic codeOrigins and evolution of genomesStochastic evolutionary algorithmsOrigins and evolution of mind and languageEcological evolutionary developmental biologyReticulate evolution (symbiosis, symbiogenesis, lateral gene transfer)Simulation of genetic and ecological systemsApplications (neural nets, machine learning, robotics)History and philosophy of scienceIn addition, the editors encourage the following types of papers for submission: Papers that extract novel biological insights from multidimensional data, using AI-driven language modelsBiological hypothesis papers producing new insights based on a body of pre-existing empirical researchPerspectives papers intended to stimulate scientific discussions and provide guidelines for future directions

Biochemical Engineering Journal

ISSN: 1369-703X
5 Year impact factor: 3.5
Impact factor: 3.7

endorsed by Division of Biochemical Engineering, The Society of Chemical Engineers, JapanBiochemical Engineering Journal welcomes submissions from NIH-funded authors. We deposit gold open access articles immediately in PubMed Central. For other articles, we shall deposit the accepted manuscript on behalf of the author to PubMed Central after 12 months (the normal embargo period for this journal is 24 months). For more information, please see here.The Biochemical Engineering Journal aims to promote progress in the crucial chemical engineering aspects of the development of biological processes associated with everything from raw materials preparation to product recovery relevant to industries as diverse as medical/healthcare, industrial biotechnology, and environmental biotechnology.The Journal welcomes full length original research papers, short communications, and review papers* in the following research fields:Biocatalysis (enzyme or microbial) and biotransformations, including immobilized biocatalyst preparation and kinetics Biosensors and Biodevices including biofabrication and novel fuel cell development Bioseparations including scale-up and protein refolding/renaturation Environmental Bioengineering including bioconversion, bioremediation, and microbial fuel cellsBioreactor Systems including characterization, optimization and scale-up Bioresources and Biorefinery Engineering including biomass conversion, biofuels, bioenergy, and optimization Industrial Biotechnology including specialty chemicals, platform chemicals and neutraceuticalsBiomaterials and Tissue Engineering including bioartificial organs, cell encapsulation, and controlled release Cell Culture Engineering (plant, animal or insect cells) including viral vectors, monoclonal antibodies, recombinant proteins, vaccines, and secondary metabolites Cell Therapies and Stem Cells including pluripotent, mesenchymal and hematopoietic stem cells; immunotherapies; tissue-specific differentiation; and cryopreservation Metabolic Engineering, Systems and Synthetic Biology including OMICS, bioinformatics, in silico biology, and metabolic flux analysis Protein Engineering including enzyme engineering and directed evolution*Authors are requested to complete a Review Proposal Form for Editorial approval prior to submission of the review article. Proposals can be submitted to [email protected] or one of the Editors.

Biochemical Pharmacology

ISSN: 0006-2952
5 Year impact factor: 5.2
Impact factor: 5.3

Biochemical Pharmacology publishes original research findings and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/translational or drug/compound-induced modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics.The journal's target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process.All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complementary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review.While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy.Reports describing experiments conducted with natural product mixtures, plant or animal extracts will not be considered for publication unless the structures and concentrations of all component substances are known, and the agents can be easily obtained by others wishing to replicate the study.The chemical structure of all novel compounds tested must be included in the submitted manuscript or be readily accessible in the published literature. References to structures in the patent literature must unambiguously identify a single molecular structure. All compounds, reagents, instrumentation and equipment employed in a study must be available from identified commercial suppliers, bio/pharmaceutical companies or from individuals holding legal rights to their use. Submissions will not be considered for publication if the chemical structures of tested compounds are not revealed, generally known, or accessible in the literature.Original research submissions must contain:A rationale for the selection of the compound/drug for study as well as for the concentrations/doses employed. Quantities used for concentration- and dose-response experiments should vary logarithmically, e.g., 1, 3, 10, 30 mg/kg, 0.1, 1.0, 10, 100 nanomolar, etc. Justification must be provided for studying only a single concentration or dose of a compound, especially as it relates to reference standards and antagonists/modulators of receptors, enzymes and signaling pathways.Justification must also be provided for the selection of the statistical tests employed as they relate to the experimental design.It is expected that all findings have been subjected to rigorous quantitative analyses, with the calculation and reporting of IC50, Ki, EC50, etc., values. These must be derived from a minimum of three (3) separate and distinct experiments, with the replicates within any single experiment being averaged to obtain a single value for that experimental series.Manuscripts that fail to meet these criteria will be subject to rejection without peer-review.US National Institutes of Health (NIH) voluntary posting ("Public Access") policy:Biochemical Pharmacology and Elsevier facilitate the author's response to the NIH Public Access Policy.

Biochemical Systematics and Ecology

ISSN: 0305-1978
5 Year impact factor: 1.4
Impact factor: 1.4

Biochemical Systematics and Ecology is devoted to the publication of original papers and reviews, both submitted and invited, in two subject areas: I) the application of biochemistry to problems relating to systematic biology of organisms (biochemical systematics); II) the role of biochemistry in interactions between organisms or between an organism and its environment (biochemical ecology).In the Biochemical Systematics subject area, comparative studies of the distribution of (secondary) metabolites within a wider taxon (e.g. genus or family) are welcome. Comparative studies, encompassing multiple accessions of each of the taxa within their distribution are particularly encouraged. Welcome are also studies combining classical chemosystematic studies (such as comparative HPLC-MS or GC-MS investigations) with (macro-) molecular phylogenetic studies. Studies that involve the comparative use of compounds to help differentiate among species such as adulterants or substitutes that illustrate the applied use of chemosystematics are welcome. In contrast, studies solely employing macromolecular phylogenetic techniques (gene sequences, RAPD studies etc.) will be considered out of scope. Discouraged are manuscripts that report known or new compounds from a single source taxon without addressing a systematic hypothesis. Also considered out of scope are studies using outdated and hard to reproduce macromolecular techniques such as RAPDs in combination with standard chemosystematic techniques such as GC-FID and GC-MS.In the Biochemical Ecology subject area, studies addressing the role compounds play in the ecology of the organisms producing them are invited. Moreover, manuscripts that address hypothesis associated with the influence of factors such as altitude, geography, and seasonal variation on the expression of primary and secondary metabolites are encouraged.Research papers should generally represent a complete investigation and not preliminary data. Preliminary reports will only be considered where findings are of sufficient interest to justify rapid publication. New Source Reports will only be considered in cases where a significant chemosystematic or ecological finding is reported. New Source Reports have to be written in a standard format (Example).

Biochemical and Biophysical Research Communications

ISSN: 0006-291X
5 Year impact factor: 2.7
Impact factor: 2.5

Biochemical and Biophysical Research Communications (BBRC) is the premier international journal devoted to the very rapid dissemination of timely and significant experimental results in diverse fields of biological research. For short communication papers, we offer the fastest submission to acceptance of any journal within life sciences, with "accept" decisions rendered within three weeks of submission. We will now consider full-length research papers and review articles.The journal covers most of areas of life science, and is divided into the following sections: BiochemistryBiophysicsCell BiologyCellular Pathology and CancerComputational Biology and BioinformaticsGeneticsImmunology and InflammationMicrobiology and VirologyNanomedicine and BionanomaterialsNeurosciencePharmacologyPhysiologyPlant BiologyStructural BiologyPlease see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center.Announcement: BBRC has traditionally only published short communications of novel results. From 2023, the journal now publishes short communications, full-length research papers, and reviews.What type of paper should I choose on submission?For short communications, we will still aim to make an accept or reject decision within two weeks of submission. If you have novel results that you can consolidate into 4,600 words, with no more than four figures, then you may continue to choose the short communication route.Short communications should be concise, no more than 4,600 words and up to four display items. They should offer novel insights and warrant a rapid peer review process. The 4,600 word count includes the title page, all sections of the manuscript (including the references), and the figure and table legends. Papers that exceed these limits will be reassigned within the submission system as a full-length research paper.If you submit a full-length research paper or a review paper, we will continue to offer a fast turnaround (with a decision after review within 45–60 days of submission), and we'll also make sure that any revisions that we request of you will not require significant resource expenditure on your part.Full-length research papers should present a comprehensive account of original research. These papers are not restricted by length or number of figures.Review papers should be authoritative, state-of-the-art accounts of the selected research field and be of high interest, balanced, and accurate. Beyond summaries of important scientific developments and ideas, authors are encouraged to identify and discuss how the field may be impacted or develop in the future, including insights that may be of significance to the scientific community. The number of co-authors of review articles is limited to five, and each author is expected to make a substantial contribution to the writing of the manuscript.There are no restrictions on length for review papers, and we welcome both comprehensive reviews and short reviews that offer an insight into more recent advances in a field.

Related subjects

Agricultural and biological sciences

Drug discovery

Immunology

Microbiology and virology

Neuroscience

Pharmaceutical sciences

Pharmacology

Toxicology

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health